Rochelle Walensky, MD, MPH

19th Director of the Centers for Disease Control and Prevention (2021-2023)

Dr. Rochelle Walensky is a member of the Operating Council of Consonance Capital Partners. Dr. Walensky served on the frontlines of the COVID-19 pandemic in Massachusetts until beginning her tenure at the Centers for Disease Control and Prevention (CDC) where she served as the 19th Director (2021-2023). Prior to that, she served as Professor of Medicine, Harvard Medical School (2012-2021), and Chief of the Division of Infectious Diseases, Massachusetts General Hospital (2017-2021). 

Dr. Walensky is an infectious disease clinician and researcher. Her research has focused on drug pricing and cost-effectiveness of HIV care and she has over 300 peer-reviewed research publications. Dr. Walensky has been an active member of policy discussions at the WHO, UNAIDS, the DHHS HIV Guidelines Committee, and the NIH Office of AIDS Research.

Dr. Walensky received her BA from Washington University in St. Louis; her MD from the Johns Hopkins School of Medicine and her MPH from the Harvard School of Public Health. She completed her Internal Medicine residency at the Johns Hopkins Hospital and her Infectious Disease fellowship at the Massachusetts General/Brigham and Women’s Hospital combined program.
 

Dr. Walensky is a member of the American Academy of Physicians, National Academy of Medicine and the Council on Foreign Relations. She currently serves on the Board of Trustees at the Doris Duke Foundation and The Carter Center.